Pathophysiology of sepsis-induced cardiomyopathy

被引:499
作者
Hollenberg, Steven M. [1 ]
Singer, Mervyn [2 ]
机构
[1] Hackensack Univ, Med Ctr, Hackensack Meridian Sch Med, Hackensack, NJ 07601 USA
[2] UCL, Bloomsbury Inst Intens Care Med, Div Med, London, England
关键词
OXIDE SYNTHASE INHIBITION; REVERSES ARTERIOLAR HYPORESPONSIVENESS; LEFT-VENTRICULAR FUNCTION; TERM RAT MODEL; SEPTIC SHOCK; NITRIC-OXIDE; MITOCHONDRIAL DYSFUNCTION; DIASTOLIC FUNCTION; MYOCARDIAL DYSFUNCTION; ORGAN DYSFUNCTION;
D O I
10.1038/s41569-020-00492-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sepsis is the life-threatening organ dysfunction caused by a dysregulated host response to infection and is the leading cause of death in intensive care units. Cardiac dysfunction caused by sepsis, usually termed sepsis-induced cardiomyopathy, is common and has long been a subject of interest. In this Review, we explore the definition, epidemiology, diagnosis and pathophysiology of septic cardiomyopathy, with an emphasis on how best to interpret this condition in the clinical context. Advances in diagnostic techniques have increased the sensitivity of detection of myocardial abnormalities but have posed challenges in linking those abnormalities to therapeutic strategies and relevant clinical outcomes. Sophisticated methodologies have elucidated various pathophysiological mechanisms but the extent to which these are adaptive responses is yet to be definitively answered. Although the indications for monitoring and treating septic cardiomyopathy are clinical and directed towards restoring tissue perfusion, a better understanding of the course and implications of septic cardiomyopathy can help to optimize interventions and improve clinical outcomes.
引用
收藏
页码:424 / 434
页数:11
相关论文
共 130 条
[1]   Elevated Cardiac Troponin I in Sepsis and Septic Shock: No Evidence for Thrombus Associated Myocardial Necrosis [J].
Altmann, David R. ;
Korte, Wolfgang ;
Maeder, Micha T. ;
Fehr, Thomas ;
Haager, Philipp ;
Rickli, Hans ;
Kleger, Gian-Reto ;
Rodriguez, Regulo ;
Ammann, Peter .
PLOS ONE, 2010, 5 (02)
[2]   Reverse Remodeling With Left Ventricular Assist Devices A Review of Clinical, Cellular, and Molecular Effects [J].
Ambardekar, Amrut V. ;
Buttrick, Peter M. .
CIRCULATION-HEART FAILURE, 2011, 4 (02) :224-233
[3]   Troponin as a risk factor for mortality in critically ill patients without acute coronary syndromes [J].
Ammann, P ;
Maggiorini, M ;
Bertel, O ;
Haenseler, E ;
Joller-Jemelka, HI ;
Oechslin, E ;
Minder, EI ;
Rickli, H ;
Fehr, T .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (11) :2004-2009
[4]   Catecholamines for inflammatory shock: a Jekyll-and-Hyde conundrum [J].
Andreis, Davide Tommaso ;
Singer, Mervyn .
INTENSIVE CARE MEDICINE, 2016, 42 (09) :1387-1397
[5]   Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock:: a randomised trial [J].
Annane, Djillali ;
Vignon, Philippe ;
Renault, Alain ;
Bollaert, Pierre-Edouard ;
Charpentier, Claire ;
Martin, Claude ;
Troche, Gilles ;
Ricard, Jean-Damien ;
Nitenberg, Gerard ;
Papazian, Laurent ;
Azoulay, Elie ;
Bellissant, Eric .
LANCET, 2007, 370 (9588) :676-684
[6]   VENTRICULOARTERIAL COUPLING IN NORMAL AND FAILING HEART IN HUMANS [J].
ASANOI, H ;
SASAYAMA, S ;
KAMEYAMA, T .
CIRCULATION RESEARCH, 1989, 65 (02) :483-493
[7]   Inhibiting nitric oxide overproduction during hypotensive sepsis increases local oxygen consumption in rat skeletal muscle [J].
Bateman, Ryon M. ;
Sharpe, Michael D. ;
Goldman, Daniel ;
Lidington, Darcy ;
Ellis, Christopher G. .
CRITICAL CARE MEDICINE, 2008, 36 (01) :225-231
[8]   Septic Cardiomyopathy [J].
Beesley, Sarah J. ;
Weber, Gerhard ;
Sarge, Todd ;
Nikravan, Sara ;
Grissom, Colin K. ;
Lanspa, Michael J. ;
Shahul, Sajid ;
Brown, Samuel M. .
CRITICAL CARE MEDICINE, 2018, 46 (04) :625-634
[9]   The mitochondrial permeability transition pore: Molecular nature and role as a target in cardioprotection [J].
Bernardi, Paolo ;
Di Lisa, Fabio .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2015, 78 :100-106
[10]   β-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans [J].
Bernardin, G ;
Strosberg, AD ;
Bernard, A ;
Mattei, M ;
Marullo, S .
INTENSIVE CARE MEDICINE, 1998, 24 (12) :1315-1322